In COVID-19, acute respiratory distress syndrome (ARDS) and thrombotic events are
frequent, life-threatening complications. Autopsies commonly show arterial thrombosis and …

The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …

The prevailing hypotheses for the persistent symptoms of Long COVID have been narrowed
down to immune dysregulation and autoantibodies, widespread organ damage, viral …

The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …

Objective While endothelial dysfunction has been implicated in the widespread
thromboinflammatory complications of COVID‐19, the upstream mediators of …

Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …

CMAJ| OCTOBER 5, 2020| VOLUME 192| ISSUE 40 E1157 in thrombotic microangiopathy
by inducing tissue factor expression, secretion of von Willebrand factor, and secretion and …

Introduction Endothelial damage and thrombosis caused by COVID-19 may imperil
cardiovascular health. More than a year since the WHO declared COVID-19 pandemic …

Background Several studies have reported that the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) can directly infect endothelial cells, and endothelial …

Patients with coronavirus disease 2019 (COVID-19) who are critically ill develop vascular
complications characterized by thrombosis of small, medium, and large vessels. Dysfunction …